Literature DB >> 32016042

Immunohistochemical screening for the diagnosis of succinate dehydrogenase-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma.

Kiril Trpkov1, Farshid Siadat1.   

Abstract

Entities:  

Year:  2019        PMID： 32016042      PMCID： PMC6976504          DOI： 10.21037/atm.2019.09.143

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  17 in total

1.  A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling.

Authors:  Evgeny Yakirevich; Siraj M Ali; Anthony Mega; Caitlin McMahon; Alexander S Brodsky; Jeffrey S Ross; Justin Allen; Julia A Elvin; Howard Safran; Murray B Resnick
Journal:  Am J Surg Pathol       Date:  2015-06       Impact factor: 6.394

2.  Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.

Authors:  Kiril Trpkov; Ondrej Hes; Abbas Agaimy; Michael Bonert; Petr Martinek; Cristina Magi-Galluzzi; Glen Kristiansen; Christine Lüders; Gabriella Nesi; Eva Compérat; Mathilde Sibony; Daniel M Berney; Rohit Mehra; Fadi Brimo; Arndt Hartmann; Arjumand Husain; Norma Frizzell; Kirsten Hills; Fiona Maclean; Bhuvana Srinivasan; Anthony J Gill
Journal:  Am J Surg Pathol       Date:  2016-07       Impact factor: 6.394

3.  Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry.

Authors:  Ying-Bei Chen; A Rose Brannon; Antoun Toubaji; Maria E Dudas; Helen H Won; Hikmat A Al-Ahmadie; Samson W Fine; Anuradha Gopalan; Norma Frizzell; Martin H Voss; Paul Russo; Michael F Berger; Satish K Tickoo; Victor E Reuter
Journal:  Am J Surg Pathol       Date:  2014-05       Impact factor: 6.394

Review 4.  Succinate dehydrogenase (SDH)-deficient neoplasia.

Authors:  Anthony J Gill
Journal:  Histopathology       Date:  2018-01       Impact factor: 5.087

5.  Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.

Authors:  Ian P M Tomlinson; N Afrina Alam; Andrew J Rowan; Ella Barclay; Emma E M Jaeger; David Kelsell; Irene Leigh; Patricia Gorman; Hanan Lamlum; Shamima Rahman; Rebecca R Roylance; Simon Olpin; Stephen Bevan; Karen Barker; Nicholas Hearle; Richard S Houlston; Maija Kiuru; Rainer Lehtonen; Auli Karhu; Susa Vilkki; Päivi Laiho; Carita Eklund; Outi Vierimaa; Kristiina Aittomäki; Marja Hietala; Pertti Sistonen; Anders Paetau; Reijo Salovaara; Riitta Herva; Virpi Launonen; Lauri A Aaltonen
Journal:  Nat Genet       Date:  2002-02-25       Impact factor: 38.330

6.  Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers.

Authors:  M Muller; S Ferlicot; M Guillaud-Bataille; G Le Teuff; C Genestie; S Deveaux; A Slama; N Poulalhon; B Escudier; L Albiges; N Soufir; M-F Avril; B Gardie; C Saldana; Y Allory; A-P Gimenez-Roqueplo; B Bressac-de Paillerets; S Richard; P R Benusiglio
Journal:  Clin Genet       Date:  2017-05-02       Impact factor: 4.438

7.  The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome.

Authors:  Maria J Merino; Carlos Torres-Cabala; Peter Pinto; William Marston Linehan
Journal:  Am J Surg Pathol       Date:  2007-10       Impact factor: 6.394

Review 8.  Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.

Authors:  Fred H Menko; Eamonn R Maher; Laura S Schmidt; Lindsay A Middelton; Kristiina Aittomäki; Ian Tomlinson; Stéphane Richard; W Marston Linehan
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

9.  Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration.

Authors:  Marie Muller; Marine Guillaud-Bataille; Julia Salleron; Catherine Genestie; Sophie Deveaux; Abdelhamid Slama; Brigitte Bressac de Paillerets; Stéphane Richard; Patrick R Benusiglio; Sophie Ferlicot
Journal:  Mod Pathol       Date:  2018-02-06       Impact factor: 7.842

10.  Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.

Authors:  Anthony J Gill; Ondrej Hes; Thomas Papathomas; Monika Šedivcová; Puay Hoon Tan; Abbas Agaimy; Per Arne Andresen; Andrew Kedziora; Adele Clarkson; Christopher W Toon; Loretta Sioson; Nicole Watson; Angela Chou; Julie Paik; Roderick J Clifton-Bligh; Bruce G Robinson; Diana E Benn; Kirsten Hills; Fiona Maclean; Nicolasine D Niemeijer; Ljiljana Vlatkovic; Arndt Hartmann; Eleonora P M Corssmit; Geert J L H van Leenders; Christopher Przybycin; Jesse K McKenney; Cristina Magi-Galluzzi; Asli Yilmaz; Darryl Yu; Katherine D Nicoll; Jim L Yong; Mathilde Sibony; Evgeny Yakirevich; Stewart Fleming; Chung W Chow; Markku Miettinen; Michal Michal; Kiril Trpkov
Journal:  Am J Surg Pathol       Date:  2014-12       Impact factor: 6.394
View more
  2 in total

1.  Expression of VEGF, CD73 and their relationship with clinical pathology, microvessel density, and prognosis in renal cell carcinoma.

Authors:  Xuefeng Mei; Jia Shu; Ruizhen Huang; Xin Chu; Ying Tian
Journal:  Transl Androl Urol       Date:  2020-06

2.  The impact of insurance status on the survival outcomes of patients with renal cell carcinoma.

Authors:  Yan Li; Ming-Xi Zhu; Bing Zhang
Journal:  Transl Androl Urol       Date:  2020-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.